Skip to main content
Watch Insiders
SYRE filings

Corporate insider profile

Michael Thomas Henderson Filing Activity

Latest reported as Corporate insider of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
2
Net open-market value
-$21,864,580.00
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

SYRELatest reported

Spyre Therapeutics, Inc.

Corporate insider

APGELatest reported

Apogee Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026Spyre Therapeutics, Inc. (SYRE)Corporate insiderSale20,000$100.00$2,000,000
Jun 22, 2026Apogee Therapeutics, Inc. (APGE)Chief Executive OfficerSale80,000$132.54$10,603,200
Jun 10, 2026Apogee Therapeutics, Inc. (APGE)Chief Executive OfficerSale20,000$83.38$1,667,622
Subscribe to see more data